Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.870000
0.1114.62%
At close: -
$1.09
0.2225.29%
After Hours: Nov 22, 7:59 PM EDT
Comments
Loading...
Biofrontera (BFRI) Forecast
NewsEarningsBiofrontera (BFRI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Biofrontera (NASDAQ:BFRI) Stock Quotes, Forecast and News Summary
Biofrontera Stock (NASDAQ: BFRI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biofrontera (BFRI) stock?
You can purchase shares of Biofrontera (NASDAQ:BFRI) through any online brokerage.
Who are Biofrontera (BFRI) competitors?
Other companies in Biofrontera’s space includes: Gelteq (NASDAQ:GELS), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
What is the forecast, or price target, for Biofrontera (BFRI) stock?
Biofrontera has a consensus price target of $7.00.
What is the current price for Biofrontera (BFRI)?
The stock price for Biofrontera (NASDAQ: BFRI) is $1.09 last updated November 22, 2024 at 7:59 PM EST.
Does Biofrontera (BFRI) pay a dividend?
There are no upcoming dividends for Biofrontera.
When is Biofrontera (NASDAQ:BFRI) reporting earnings?
Biofrontera’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Biofrontera (BFRI) going to split?
There is no upcoming split for Biofrontera.
What sector and industry does Biofrontera (BFRI) operate in?
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.